Hospital groups are already pushing back on Rep. Chris Collins' (R-NY) move to create a 340B user fee program, which both the Obama and Trump administration have proposed, saying the Health Resources and Services Administration shouldn't receive more resources since the agency is not implementing oversight on drug manufacturers and has yet to make the 340B ceiling price website public. Collins on Wednesday (June 27) introduced the Drug Discount Accountability Act, which would require hospitals to report their total 340B...